Tick-borne Encephalitis Virus Research in Limousin
VITAL
1 other identifier
observational
878
1 country
1
Brief Summary
Cases of encephalitis of varying severity have been described in recent years in eastern France involving tick-borne encephalitis virus (TBEV). The main objective is to demonstrate the presence of TBEV in Limousin, in patients with a positive Lyme serology, or a neurological picture compatible with TBEV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedStudy Start
First participant enrolled
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2023
CompletedApril 8, 2026
April 1, 2026
27 days
July 4, 2023
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of anti-TBEV antibodies in serum
The primary endpoint is the detection of anti-TBEV antibodies in the serum of the study population.
month 1
Secondary Outcomes (1)
Search for the presence of TBEV in the CSF in case of positive serology. Determine the risk factors associated with this infection.
month 2
Interventions
we will measure by ELISA in microplates the anti-TBEV IgG as well as the anti-TBEV IgM on the sera + in TBEV IgG. We will then send a patient questionnaire with an information note to document the context of this TBEV seropositivity and to eliminate false-positivities (vaccination). Finally, we will perform PCR on CSF if serum positive and CSF available
Eligibility Criteria
patients with Lyme serology from our GLIMS laboratory software (with positive or negative results)
You may qualify if:
- Patient with Lyme serology. Neurological picture compatible with neuroborreliosis or encephalitis.
- No objection from the patient to the use of biobank samples
You may not qualify if:
- Patient's opposition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Limoges University Hosiptal
Limoges, 87000, France
Related Publications (1)
Bisserier E, Perraud A, Ayhan N, Durand GA, de Lamballerie X, Hantz S. Serological evidence of tick-borne encephalitis virus in limousin, france. Int J Infect Dis. 2026 Apr;165:108424. doi: 10.1016/j.ijid.2026.108424. Epub 2026 Jan 27.
PMID: 41610944RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2023
First Posted
July 12, 2023
Study Start
July 17, 2023
Primary Completion
August 13, 2023
Study Completion
August 13, 2023
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share